Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

Increased levels of circulating neurotoxic metabolites in patients with mild Covid19

View ORCID ProfileEstibaliz Santiago-Mujika, View ORCID ProfileKevin Heinrich, Sonia George, View ORCID ProfileColt D Capan, Cameron Forton, View ORCID ProfileZachary Madaj, View ORCID ProfileAmanda R Burmeister, Matthew Sims, View ORCID ProfileJ Andrew Pospisilik, View ORCID ProfilePatrik Brundin, View ORCID ProfileStewart F Graham, View ORCID ProfileLena Brundin
doi: https://doi.org/10.1101/2022.06.22.497189
Estibaliz Santiago-Mujika
1Parkinson’s Disease Center, Department of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI 49503, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Estibaliz Santiago-Mujika
Kevin Heinrich
2Quire Inc., Memphis, TN 38103, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kevin Heinrich
Sonia George
1Parkinson’s Disease Center, Department of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI 49503, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Colt D Capan
1Parkinson’s Disease Center, Department of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI 49503, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Colt D Capan
Cameron Forton
1Parkinson’s Disease Center, Department of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI 49503, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zachary Madaj
3Bioinformatics & Biostatistics core, Van Andel Institute, Grand Rapids, MI 49503, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Zachary Madaj
Amanda R Burmeister
1Parkinson’s Disease Center, Department of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI 49503, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Amanda R Burmeister
Matthew Sims
4Section of Infectious Diseases and International Medicine, Department of Internal Medicine, Beaumont Health, Royal Oak, Michigan 48073, USA
5Department of Foundational Medical Studies, Oakland University William Beaumont School of Medicine, Rochester, Michigan, USA
6Department of Internal Medicine, Oakland University William Beaumont School of Medicine, Rochester, Michigan, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J Andrew Pospisilik
1Parkinson’s Disease Center, Department of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI 49503, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for J Andrew Pospisilik
Patrik Brundin
1Parkinson’s Disease Center, Department of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI 49503, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Patrik Brundin
Stewart F Graham
7Metabolomics Department, Beaumont Research Institute, Beaumont Health, Royal Oak, Michigan 48073, USA
8Oakland University-William Beaumont School of Medicine, Rochester, MI 48309, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Stewart F Graham
Lena Brundin
1Parkinson’s Disease Center, Department of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI 49503, USA
9Department of Psychiatry, Michigan State University College of Human Medicine, Grand Rapids, MI 49503, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lena Brundin
  • For correspondence: Lena.Brundin@vai.org
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Preview PDF
Loading

Abstract

SARS-CoV-2 corona virus causes a multi-faceted and poorly defined clinical and pathological phenotype involving hyperinflammation, cytokine release. And long-term cognitive deficits, with an undefined neuropathological mechanism. Inflammation increases the activity of the kynurenine pathway, which is linked to neurodegenerative and psychiatric disorders. We sought to determine whether the kynurenine pathway is impacted in patients with mild COVID-19, leading to elevated neurotoxic metabolites in blood, and whether such changes are associated with pro-inflammatory cytokines. Serum samples were taken from 150 patients and analyzed by ELISA and ultra-high performance liquid chromatography (UHPLC). The data were analyzed using multiple linear regression models adjusted for age and sex. We found increased levels of kynurenine, quinolinic acid and 3-hydroxykynurenine in serum from patients with mild COVID-19, together with increased levels of IL-6, ICAM-1, VCAM-1 and neopterin. The levels of neurotoxic metabolites were significantly associated with key inflammatory cytokines including IL-6 and TNFα. The COVID-19 risk-factor hypertension was associated with the highest levels of neurotoxic metabolites in plasma. These neuroactive metabolites could be part of the pathological mechanisms underlying cognitive impairment during and post-COVID and should be explored as potential biomarkers for long-COVID symptoms.

Competing Interest Statement

P.B. has received support as a consultant from Calico Life Sciences, CureSen, Enterin Inc, Idorsia Pharmaceuticals, Lundbeck A/S, AbbVie, Fujifilm-Cellular Dynamics International, and Axial Therapeutics. He has received commercial support for research from Lundbeck A/S and F. Hoffman-La Roche. He has ownership interests in Acousort AB, Axial Therapeutics, Enterin Inc and RYNE Biotechnology. During the time that this paper was written he became an employee of F. Hoffman-La Roche, although none of the data were generated by this company.

Footnotes

  • The affiliations for Matthew Sims, the analysis section on material and methods, as well as a sentence in the abstract have been updated and corrected

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted June 24, 2022.
Download PDF

Supplementary Material

Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Increased levels of circulating neurotoxic metabolites in patients with mild Covid19
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Increased levels of circulating neurotoxic metabolites in patients with mild Covid19
Estibaliz Santiago-Mujika, Kevin Heinrich, Sonia George, Colt D Capan, Cameron Forton, Zachary Madaj, Amanda R Burmeister, Matthew Sims, J Andrew Pospisilik, Patrik Brundin, Stewart F Graham, Lena Brundin
bioRxiv 2022.06.22.497189; doi: https://doi.org/10.1101/2022.06.22.497189
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Increased levels of circulating neurotoxic metabolites in patients with mild Covid19
Estibaliz Santiago-Mujika, Kevin Heinrich, Sonia George, Colt D Capan, Cameron Forton, Zachary Madaj, Amanda R Burmeister, Matthew Sims, J Andrew Pospisilik, Patrik Brundin, Stewart F Graham, Lena Brundin
bioRxiv 2022.06.22.497189; doi: https://doi.org/10.1101/2022.06.22.497189

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Neuroscience
Subject Areas
All Articles
  • Animal Behavior and Cognition (3592)
  • Biochemistry (7562)
  • Bioengineering (5508)
  • Bioinformatics (20762)
  • Biophysics (10309)
  • Cancer Biology (7967)
  • Cell Biology (11627)
  • Clinical Trials (138)
  • Developmental Biology (6602)
  • Ecology (10190)
  • Epidemiology (2065)
  • Evolutionary Biology (13594)
  • Genetics (9532)
  • Genomics (12834)
  • Immunology (7917)
  • Microbiology (19525)
  • Molecular Biology (7651)
  • Neuroscience (42027)
  • Paleontology (307)
  • Pathology (1254)
  • Pharmacology and Toxicology (2196)
  • Physiology (3263)
  • Plant Biology (7029)
  • Scientific Communication and Education (1294)
  • Synthetic Biology (1949)
  • Systems Biology (5422)
  • Zoology (1114)